Safety and efficacy of uric acid in patients with acute stroke (URICO-ICTUS): a randomised, double-blind phase 2b/3 trial. (Q50702011)

17 March 2018

title

Safety and efficacy of uric acid in patients with acute stroke (URICO-ICTUS): a randomised, double-blind phase 2b/3 trial. (English)

1 reference

17 March 2018

Angel Chamorro

1

0 references

Luis San Román

object named as

Luis San Román

13

0 references

Tomás Segura

object named as

Tomás Segura

4

0 references

Ferran Torres

object named as

Ferran Torres

15

0 references

author name string

Sergio Amaro

2

1 reference

17 March 2018

Mar Castellanos

3

1 reference

17 March 2018

Juan Arenillas

5

1 reference

17 March 2018

Joan Martí-Fábregas

6

1 reference

17 March 2018

Jaime Gállego

7

1 reference

17 March 2018

Jurek Krupinski

8

1 reference

17 March 2018

Meritxell Gomis

9

1 reference

17 March 2018

David Cánovas

10

1 reference

17 March 2018

Xavier Carné

11

1 reference

17 March 2018

Ramón Deulofeu

12

1 reference

17 March 2018

Laura Oleaga

14

1 reference

17 March 2018

Anna M Planas

16

1 reference

17 March 2018

URICO-ICTUS Investigators

17

1 reference

17 March 2018

publication date

2 April 2014

1 reference

17 March 2018

published in

Lancet Neurology

1 reference

17 March 2018

volume

13

1 reference

17 March 2018

issue

5

1 reference

17 March 2018

page(s)

453-460

1 reference

17 March 2018

Tissue plasminogen activator for acute ischemic stroke

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970054-7

7 January 2021

Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970054-7

7 January 2021

Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970054-7

7 January 2021

Translational stroke research of the combination of thrombolysis and antioxidant therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970054-7

7 January 2021

Two independent mutational events in the loss of urate oxidase during hominoid evolution

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970054-7

7 January 2021

Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970054-7

7 January 2021

Prognostic significance of uric acid serum concentration in patients with acute ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970054-7

7 January 2021

Uric Acid Levels Are Relevant in Patients With Stroke Treated With Thrombolysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970054-7

7 January 2021

A pilot study of dual treatment with recombinant tissue plasminogen activator and uric acid in acute ischemic stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970054-7

7 January 2021

Influence of recanalization on uric acid patterns in acute ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970054-7

7 January 2021

Uric acid protects neurons against excitotoxic and metabolic insults in cell culture, and against focal ischemic brain injury in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970054-7

7 January 2021

Uric acid reduces brain damage and improves the benefits of rt-PA in a rat model of thromboembolic stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970054-7

7 January 2021

Course of matrix metalloproteinase-9 isoforms after the administration of uric acid in patients with acute stroke: a proof-of-concept study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970054-7

7 January 2021

Uric acid administration for neuroprotection in patients with acute brain ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970054-7

7 January 2021

The URICO-ICTUS study, a phase 3 study of combined treatment with uric acid and rtPA administered intravenously in acute ischaemic stroke patients within the first 4.5 h of onset of symptoms.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970054-7

7 January 2021

Interobserver agreement for the assessment of handicap in stroke patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970054-7

7 January 2021

Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970054-7

7 January 2021

Statistical analysis of the primary outcome in acute stroke trials

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970054-7

7 January 2021

Outcomes of Intravenous Thrombolysis After Dissemination of the Stroke Code and Designation of New Referral Hospitals in Catalonia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970054-7

7 January 2021

Enhancing the Development and Approval of Acute Stroke Therapies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970054-7

7 January 2021

Free radicals in cerebral ischemia.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970054-7

7 January 2021

NXY-059 for the treatment of acute ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970054-7

7 January 2021

Comparison of the radical trapping ability of PBN, S-PPBN and NXY-059.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970054-7

7 January 2021

Heart Disease and Stroke Statistics--2013 Update: A Report From the American Heart Association

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970054-7

7 January 2021

Glucose and NADPH oxidase drive neuronal superoxide formation in stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970054-7

7 January 2021

10.1016/S1474-4422(14)70054-7

Identifiers

DOI

1 reference

17 March 2018

PubMed ID

24703208

1 reference

17 March 2018